AUM Biosciences to develop Inflection’s cancer therapy
Biotechnology firm AUM Biosciences has entered a global licence agreement for Inflection Biosciences’ series of...
Read More...
Focus:
Singapore
-
![Nefecon Greater China]()
Everest Medicines to commercialise Calliditas’ Nefecon in Greater China and Singapore
Sweden-based Calliditas Therapeutics has announced that Everest Medicines will commercialise its IgA nephropathy (IgAN) drug...
Read More...
-
![ASLAN Pharmaceuticals acquires rights to CSL’s atopic dermatitis asset]()
ASLAN Pharmaceuticals acquires rights to atopic dermatitis asset
ASLAN Pharmaceuticals has amended its licensing agreement with CSL to obtain complete worldwide rights to...
Read More...
-
![]()
AI technology to help design personalised combination therapy
A research team led by the National University of Singapore (NUS) has developed an artificial...
Read More...
-
Chugai Pharmaceutical to expand Singaporean research subsidiary
Japan-based Chugai Pharmaceutical has revealed plans to expand its research subsidiary in Singapore, Chugai Pharmabody...
Read More...
-
Deals this week: Sanofi, EBOS, Menarini Asia-Pacific Holdings
Sanofi has signed an agreement with Evotec to integrate its infectious disease unit into the...
Read More...
-
M&As this week: Strides Pharma Asia, GlaxoSmithKline
Strides Pharma Asia has agreed to purchase a 55% stake in South African pharmaceutical company...
Read More...
Close
Close
Close
Go Top